Wei-Ru Xu

424 total citations
16 papers, 326 citations indexed

About

Wei-Ru Xu is a scholar working on Oncology, Complementary and alternative medicine and Molecular Biology. According to data from OpenAlex, Wei-Ru Xu has authored 16 papers receiving a total of 326 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Complementary and alternative medicine and 4 papers in Molecular Biology. Recurrent topics in Wei-Ru Xu's work include Acupuncture Treatment Research Studies (4 papers), Cancer Treatment and Pharmacology (3 papers) and Estrogen and related hormone effects (3 papers). Wei-Ru Xu is often cited by papers focused on Acupuncture Treatment Research Studies (4 papers), Cancer Treatment and Pharmacology (3 papers) and Estrogen and related hormone effects (3 papers). Wei-Ru Xu collaborates with scholars based in China. Wei-Ru Xu's co-authors include Guowang Yang, Xiaomin Wang, Mingwei Yu, Wei Hou, Xiaoyun Zhu, Hongsheng Lin, Xin Qi, Ying Zhang, Baojin Hua and Wei Hou and has published in prestigious journals such as Medicine, Frontiers in Oncology and Journal of Experimental & Clinical Cancer Research.

In The Last Decade

Wei-Ru Xu

14 papers receiving 319 citations

Peers

Wei-Ru Xu

ONCOL

CAM

PHARM

Yajie Xiao China

Zhang Li China

Yaodong Zhu China

Wanfu Lin China

Zheng Xiao China

Guangyi Gao China

Hye-Nan Kim South Korea

Qian Zuo China

Juan Zou China

Cheng Qian China

Yajie Xiao China

Wei-Ru Xu

118 ×0.8

97 ×0.8

ONCOL

66 ×0.9

CAM

48 ×1.0

PHARM

16 ×0.3

PHARM

Citations per year, relative to Wei-Ru Xu Wei-Ru Xu (= 1×) peers Yajie Xiao

Countries citing papers authored by Wei-Ru Xu

Since Specialization

Citations

This map shows the geographic impact of Wei-Ru Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei-Ru Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei-Ru Xu more than expected).

Fields of papers citing papers by Wei-Ru Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei-Ru Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei-Ru Xu. The network helps show where Wei-Ru Xu may publish in the future.

Co-authorship network of co-authors of Wei-Ru Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei-Ru Xu. A scholar is included among the top collaborators of Wei-Ru Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei-Ru Xu. Wei-Ru Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Yang, Wenjing, et al.. (2025). Almonertinib-induced interstitial lung disease in an NSCLC patient co-harboring EGFR Ex19del mutation and MET de novo amplification: a case report and literature review. Frontiers in Oncology. 15. 1481244–1481244.

Xu, Jianbo, Qing Zhang, Na Xue, Cui Zhang, & Wei-Ru Xu. (2025). The therapeutic effect of acupuncture in the treatment of chemotherapy-induced peripheral neuropathy: a randomized controlled trial. Frontiers in Oncology. 15. 1500410–1500410.

Li, Qiwei, Mingwei Yu, Xiaomin Wang, et al.. (2020). Efficacy of acupuncture in the prevention and treatment of chemotherapy-induced nausea and vomiting in patients with advanced cancer: a multi-center, single-blind, randomized, sham-controlled clinical research. Chinese Medicine. 15(1). 57–57. 31 indexed citations

Peng, Nan, Mingwei Yu, Guowang Yang, et al.. (2017). Effects of the Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: A randomized, controlled clinical trial. The Breast. 37. 18–27. 9 indexed citations

Li, Qiwei, Mingwei Yu, Guowang Yang, et al.. (2017). Effect of acupuncture in prevention and treatment of chemotherapy-induced nausea and vomiting in patients with advanced cancer: study protocol for a randomized controlled trial. Trials. 18(1). 185–185. 12 indexed citations

Yang, Yong, Fuhao Chu, Wei-Ru Xu, et al.. (2017). Identification of regulatory role of DNA methylation in colon cancer gene expression via systematic bioinformatics analysis. Medicine. 96(47). e8487–e8487. 17 indexed citations

Zhang, Ying, et al.. (2016). [Oxymatrine Diminished the Side Population and Inhibited Wnt/p-catenin Signaling Pathway in MCF- 7 Breast Cancer Cells].. PubMed. 36(12). 1504–1509. 1 indexed citations

Han, Yan, Huan Wang, Wei-Ru Xu, et al.. (2015). Chinese herbal medicine as maintenance therapy for improving the quality of life for advanced non-small cell lung cancer patients. Complementary Therapies in Medicine. 24. 81–89. 45 indexed citations

Xu, Wei-Ru, Guowang Yang, Qing Zhang, et al.. (2014). The Possibility of Traditional Chinese Medicine as Maintenance Therapy for Advanced Nonsmall Cell Lung Cancer. Evidence-based Complementary and Alternative Medicine. 2014(1). 278917–278917. 37 indexed citations

10.

Peng, Nan, Yi Zhang, Cong Ma, et al.. (2014). Effects of the traditional Chinese medicine Yi Shen Jian Gu granules on aromatase inhibitor-associated musculoskeletal symptoms: a study protocol for a multicenter, randomized, controlled clinical trial. Trials. 15(1). 171–171. 3 indexed citations

11.

Xu, Wei-Ru, Hongsheng Lin, Xinyi Chen, & Ying Zhang. (2011). Estrogen receptor of breast cancer stem cells depending on the original breast cancers. Medical Hypotheses. 77(1). 71–73. 4 indexed citations

12.

Xu, Wei-Ru, Hongsheng Lin, Xinyi Chen, & Ying Zhang. (2011). Yin-yang Balance Therapy on Regulating Cancer Stem Cells. Journal of Traditional Chinese Medicine. 31(2). 158–160. 11 indexed citations

13.

Xu, Wei-Ru, Hongsheng Lin, Ying Zhang, et al.. (2011). Compound Kushen Injection suppresses human breast cancer stem-like cells by down-regulating the canonical Wnt/β-catenin pathway. Journal of Experimental & Clinical Cancer Research. 30(1). 103–103. 57 indexed citations

14.

Zhang, Ying, Yong Zhang, Wei Hou, et al.. (2010). Oxymatrine diminishes the side population and inhibits the expression of β-catenin in MCF-7 breast cancer cells. Medical Oncology. 28(S1). 99–107. 65 indexed citations

15.

Xu, Wei-Ru, et al.. (2010). [Clinical randomized controlled study on acupuncture for treatment of peripheral neuropathy induced by chemotherapeutic drugs].. PubMed. 30(6). 457–60. 33 indexed citations

16.

Xu, Wei-Ru & Baojin Hua. (2008). [Progress on the treatment of chemotherapy-induced peripheral neuropathy by Chinese and Western medicine].. PubMed. 28(11). 1049–52. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact